These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 31774391)
1. Dengue virus infects the mouse eye following systemic or intracranial infection and induces inflammatory responses. Norbury AJ; Calvert JK; Al-Shujairi WH; Cabezas-Falcon S; Tang V; Ong LC; Alonso SL; Smith JR; Carr JM J Gen Virol; 2020 Jan; 101(1):79-85. PubMed ID: 31774391 [TBL] [Abstract][Full Text] [Related]
2. Viperin is anti-viral Al Shujairi WH; Kris LP; van der Hoek K; Cowell E; Bracho-Granado G; Woodgate T; Beard MR; Carr JM J Gen Virol; 2021 Oct; 102(10):. PubMed ID: 34665110 [TBL] [Abstract][Full Text] [Related]
3. Intracranial Injection of Dengue Virus Induces Interferon Stimulated Genes and CD8+ T Cell Infiltration by Sphingosine Kinase 1 Independent Pathways. Al-Shujairi WH; Clarke JN; Davies LT; Alsharifi M; Pitson SM; Carr JM PLoS One; 2017; 12(1):e0169814. PubMed ID: 28095439 [TBL] [Abstract][Full Text] [Related]
4. Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection. Pinto AK; Brien JD; Lam CY; Johnson S; Chiang C; Hiscott J; Sarathy VV; Barrett AD; Shresta S; Diamond MS mBio; 2015 Sep; 6(5):e01316-15. PubMed ID: 26374123 [TBL] [Abstract][Full Text] [Related]
5. Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines. Züst R; Toh YX; Valdés I; Cerny D; Heinrich J; Hermida L; Marcos E; Guillén G; Kalinke U; Shi PY; Fink K J Virol; 2014 Jul; 88(13):7276-85. PubMed ID: 24741106 [TBL] [Abstract][Full Text] [Related]
6. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice. Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279 [TBL] [Abstract][Full Text] [Related]
7. Susceptibility and initial immune response of Tupaia belangeri cells to dengue virus infection. Kayesh MEH; Kitab B; Sanada T; Hayasaka D; Morita K; Kohara M; Tsukiyama-Kohara K Infect Genet Evol; 2017 Jul; 51():203-210. PubMed ID: 28392469 [TBL] [Abstract][Full Text] [Related]
8. A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease. Sarathy VV; White M; Li L; Gorder SR; Pyles RB; Campbell GA; Milligan GN; Bourne N; Barrett AD J Virol; 2015 Jan; 89(2):1254-66. PubMed ID: 25392217 [TBL] [Abstract][Full Text] [Related]
9. The roles of IRF-3 and IRF-7 in innate antiviral immunity against dengue virus. Chen HW; King K; Tu J; Sanchez M; Luster AD; Shresta S J Immunol; 2013 Oct; 191(8):4194-201. PubMed ID: 24043884 [TBL] [Abstract][Full Text] [Related]
10. Dengue Virus-Infected Dendritic Cells, but Not Monocytes, Activate Natural Killer Cells through a Contact-Dependent Mechanism Involving Adhesion Molecules. Costa VV; Ye W; Chen Q; Teixeira MM; Preiser P; Ooi EE; Chen J mBio; 2017 Aug; 8(4):. PubMed ID: 28765218 [TBL] [Abstract][Full Text] [Related]
11. A lethal model of disseminated dengue virus type 1 infection in AG129 mice. Milligan GN; Sarathy VV; White MM; Greenberg MB; Campbell GA; Pyles RB; Barrett ADT; Bourne N J Gen Virol; 2017 Oct; 98(10):2507-2519. PubMed ID: 28949904 [TBL] [Abstract][Full Text] [Related]
12. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection. Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W Front Immunol; 2018; 9():597. PubMed ID: 29740424 [TBL] [Abstract][Full Text] [Related]
13. Subversion of early innate antiviral responses during antibody-dependent enhancement of Dengue virus infection induces severe disease in immunocompetent mice. Costa VV; Fagundes CT; Valadão DF; Ávila TV; Cisalpino D; Rocha RF; Ribeiro LS; Ascenção FR; Kangussu LM; Celso MQ; Astigarraga RG; Gouveia FL; Silva TA; Bonaventura D; Sampaio Dde A; Leite AC; Teixeira MM; Souza DG Med Microbiol Immunol; 2014 Aug; 203(4):231-50. PubMed ID: 24723052 [TBL] [Abstract][Full Text] [Related]
14. Characterization of lethal dengue virus type 4 (DENV-4) TVP-376 infection in mice lacking both IFN-α/β and IFN-γ receptors (AG129) and comparison with the DENV-2 AG129 mouse model. Sarathy VV; Infante E; Li L; Campbell GA; Wang T; Paessler S; Robert Beatty P; Harris E; Milligan GN; Bourne N; Barrett ADT J Gen Virol; 2015 Oct; 96(10):3035-3048. PubMed ID: 26296350 [TBL] [Abstract][Full Text] [Related]
15. IFN-γ production depends on IL-12 and IL-18 combined action and mediates host resistance to dengue virus infection in a nitric oxide-dependent manner. Fagundes CT; Costa VV; Cisalpino D; Amaral FA; Souza PR; Souza RS; Ryffel B; Vieira LQ; Silva TA; Atrasheuskaya A; Ignatyev G; Sousa LP; Souza DG; Teixeira MM PLoS Negl Trop Dis; 2011 Dec; 5(12):e1449. PubMed ID: 22206036 [TBL] [Abstract][Full Text] [Related]
16. Patterns of Cellular Immunity Associated with Experimental Infection with rDEN2Δ30 (Tonga/74) Support Its Suitability as a Human Dengue Virus Challenge Strain. Grifoni A; Angelo M; Sidney J; Paul S; Peters B; de Silva AD; Phillips E; Mallal S; Diehl SA; Botten J; Boyson J; Kirkpatrick BD; Whitehead SS; Durbin AP; Sette A; Weiskopf D J Virol; 2017 Apr; 91(8):. PubMed ID: 28148797 [TBL] [Abstract][Full Text] [Related]
17. The Role of Heterotypic DENV-specific CD8 Talarico LB; Batalle JP; Byrne AB; Brahamian JM; Ferretti A; García AG; Mauri A; Simonetto C; Hijano DR; Lawrence A; Acosta PL; Caballero MT; Paredes Rojas Y; Ibañez LI; Melendi GA; Rey FA; Damonte EB; Harris E; Polack FP EBioMedicine; 2017 Jun; 20():202-216. PubMed ID: 28483582 [TBL] [Abstract][Full Text] [Related]
18. A model of DENV-3 infection that recapitulates severe disease and highlights the importance of IFN-γ in host resistance to infection. Costa VV; Fagundes CT; Valadão DF; Cisalpino D; Dias AC; Silveira KD; Kangussu LM; Ávila TV; Bonfim MR; Bonaventura D; Silva TA; Sousa LP; Rachid MA; Vieira LQ; Menezes GB; de Paula AM; Atrasheuskaya A; Ignatyev G; Teixeira MM; Souza DG PLoS Negl Trop Dis; 2012; 6(5):e1663. PubMed ID: 22666512 [TBL] [Abstract][Full Text] [Related]
19. Characterization of a murine model of non-lethal, symptomatic dengue virus infection. Sarathy VV; White M; Li L; Kaiser JA; Campbell GA; Milligan GN; Bourne N; Barrett ADT Sci Rep; 2018 Mar; 8(1):4900. PubMed ID: 29559699 [TBL] [Abstract][Full Text] [Related]
20. Innate immunity to dengue virus infection and subversion of antiviral responses. Green AM; Beatty PR; Hadjilaou A; Harris E J Mol Biol; 2014 Mar; 426(6):1148-60. PubMed ID: 24316047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]